Search results
Law Roach Broke His Tooth Snacking on a Jolly Rancher After the Met
Us Weekly via AOL· 19 hours agoTaylor Hill/Getty Images Zendaya’s stylist Law Roach didn’t let a little dental emergency ruin...
Coach parent Tapestry cuts sales forecast on tepid demand in US, China
Reuters via Yahoo Finance· 6 hours ago(Reuters) -Coach handbag maker Tapestry cut its annual sales forecast and missed third-quarter...
Sanjaya Kumar Mishra takes oath as President of GST Appellate Tribunal
Investing.com· 3 days agoSanjaya Kumar Mishra takes oath as President of GST Appellate Tribunal
Major hospital's radiology department and critical care unit 'crumbling'
Daily Express· 18 hours agoA UK hospital is in dire straits as its outpatients, radiology department and critical care unit are...
Indians at Met Gala 2024: Alia Bhatt, Natasha Poonawalla & More
COMINGSOON.net via Yahoo News· 2 days agoThe Met Gala 2024, held at New York’s Metropolitan Museum of Art, was a dazzling showcase of fashion...
AI integration in business: Transforming industries - SiliconANGLE
SiliconANGLE· 1 hour agoThe swift advancement of technology, particularly through artificial intelligence, is transforming...
ICICI Bank enables NRI customers to use international mobile number to make UPI payments in India
FOX 23 News Albany· 2 days agoICICI Bank today announced that it has enabled NRI customers to use their international mobile...
Tapestry Misses Quarterly Revenue Expectations
The Business of Fashion· 3 hours agoThe company’s net sales came in at $1.48 billion in the quarter ended March 30, compared to analysts’ average estimate of $1.50 billion, according to...
Nepal court orders limit on Everest climbing permits
AFP via Yahoo News· 6 days agoNepal's Supreme Court has ordered the government to limit the number of mountaineering permits issued for Everest and other peaks, a lawyer confirmed...
Amgen jumps after teasing weight-loss drug data, rival stocks slide
AOL· 6 days ago(Reuters) -Amgen shares jumped 14% premarket on Friday after the U.S. drugmaker hinted at encouraging interim trial data on its experimental obesity drug, denting rival stocks such as Novo Nordisk ...
